Class III · Lower riskActive recall
Glimepiride
Unlikely to cause harm — often a labeling or packaging issue.
Does this affect you?
Check your lot numberLot: T2303609; Exp. 06/2026 Lot: T2303610; Exp. 06/2026
Where it was soldNationwide
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Misprint on tablet
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
Made byDr. Reddy's Laboratories Limited
| Brand name | GLIMEPIRIDE |
| Generic name | GLIMEPIRIDE |
| Active ingredient(s) | GLIMEPIRIDE |
| Distributed by / for | Dr. Reddy's Laboratories, Inc. |
| NDC | 55111-320-05 |
Show the full FDA record
| Full product label | Glimepiride Tablets, USP 1mg, 500-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam-532 409 INDIA, NDC: 55111-320-05 |
| Recalling firm | Dr. Reddy's Laboratories, Inc. |
| Distribution | Nationwide |
| Quantity | 14,425 bottles |
| Recall initiated | 2024-01-18 |
| Report date | 2024-02-14 |
| Recall completed | — |
| Recall number | D-0313-2024 |
| Classification | Class III |
| FDA status | Ongoing |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.